Table of Contents Author Guidelines Submit a Manuscript
Cellular Oncology
Volume 31, Issue 6, Pages 423-436
http://dx.doi.org/10.3233/CLO-2009-0504

Co-Expression of Plexin-B1 and Met in Human Breast and Ovary Tumours Enhances the Risk of Progression

Guido Valente,1 Giuseppina Nicotra,1 Marisa Arrondini,1 Roberta Castino,2 Lorena Capparuccia,3 Maria Prat,4 Simonetta Kerim,5 Luca Tamagnone,5 and Ciro Isidoro2

1Pathology Section, Department of Clinical and Experimental Medicine, Amedeo Avogadro University, Novara, Italy
2Laboratory of Molecular Pathology, Department of Medical Sciences, Amedeo Avogadro University, Novara, Italy
3Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, Candiolo (TO), Italy
4Laboratory of Histology, Department of Medical Sciences, Amedeo Avogadro University, Novara, Italy
5Cytogenetics Unit, Department of Laboratory Diagnostics, San Giovanni Hospital, Torino, Italy

Copyright © 2009 Hindawi Publishing Corporation and the authors. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Guido Valente, Giuseppina Nicotra, Marisa Arrondini, et al., “Co-Expression of Plexin-B1 and Met in Human Breast and Ovary Tumours Enhances the Risk of Progression,” Cellular Oncology, vol. 31, no. 6, pp. 423-436, 2009. https://doi.org/10.3233/CLO-2009-0504.